Australian alcohol-attributable harm visualisation tool
Estimated counts of Australian alcohol-attributable deaths
Scenario 1 (IHD relative risk source*) | Scenario 2 (IHD relative risk source+) | Scenario 3 (No protective effect±) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Condition | Age group | Male | Female | Total | Male | Female | Total | Male | Female | Total |
Cancers | 15 to 34 | 5.16 | 4.15 | 9.31 | 5.16 | 4.15 | 9.31 | 5.16 | 4.15 | 9.31 |
35 to 64 | 450.18 | 197.15 | 647.33 | 450.18 | 197.15 | 647.33 | 450.18 | 197.15 | 647.33 | |
65+ | 970.13 | 439.09 | 1409.22 | 970.13 | 439.09 | 1409.22 | 970.13 | 439.09 | 1409.22 | |
Cardiovascular diseases | 15 to 34 | 2.50 | 0.54 | 3.04 | 4.38 | 0.54 | 4.92 | 4.34 | 1.36 | 5.70 |
35 to 64 | 88.10 | 40.32 | 128.41 | 206.51 | 40.32 | 246.83 | 253.11 | 88.52 | 341.63 | |
65+ | -220.05 | -337.52 | -557.57 | 601.07 | -337.52 | 263.56 | 1055.98 | 1080.46 | 2136.44 | |
Digestive diseases | 15 to 34 | 13.42 | 11.83 | 25.25 | 13.42 | 11.83 | 25.25 | 13.42 | 11.92 | 25.34 |
35 to 64 | 564.72 | 220.87 | 785.59 | 564.72 | 220.87 | 785.59 | 564.72 | 222.75 | 787.47 | |
65+ | 357.56 | 154.97 | 512.53 | 357.56 | 154.97 | 512.53 | 357.56 | 161.42 | 518.97 | |
Endocrine conditions | 15 to 34 | n.p. | n.p. | n.p. | n.p. | n.p. | n.p. | n.p. | n.p. | n.p. |
35 to 64 | n.p. | n.p. | n.p. | n.p. | n.p. | n.p. | n.p. | n.p. | n.p. | |
65+ | 31.17 | -149.37 | -118.19 | 31.17 | -149.37 | -118.19 | 31.20 | 24.73 | 55.94 | |
Infectious diseases | 15 to 34 | 0.77 | 0.71 | 1.48 | 0.77 | 0.71 | 1.48 | 0.77 | 0.71 | 1.48 |
35 to 64 | 18.79 | 6.07 | 24.87 | 18.79 | 6.07 | 24.87 | 18.79 | 6.07 | 24.87 | |
65+ | 128.78 | 87.60 | 216.38 | 128.78 | 87.60 | 216.38 | 128.78 | 87.60 | 216.38 | |
Injuries (Intentional) | 0 to 14 | 1.12 | 1.12 | 2.24 | 1.12 | 1.12 | 2.24 | 1.12 | 1.12 | 2.24 |
15 to 34 | 107.32 | 27.98 | 135.30 | 107.32 | 27.98 | 135.30 | 107.32 | 27.98 | 135.30 | |
35 to 64 | 152.43 | 40.71 | 193.13 | 152.43 | 40.71 | 193.13 | 152.43 | 40.71 | 193.13 | |
65+ | 17.34 | 6.44 | 23.78 | 17.34 | 6.44 | 23.78 | 17.34 | 6.44 | 23.78 | |
Injuries (Unintentional) | 15 to 34 | 97.15 | 15.81 | 112.96 | 97.15 | 15.81 | 112.96 | 97.15 | 15.81 | 112.96 |
35 to 64 | 139.17 | 33.17 | 172.34 | 139.17 | 33.17 | 172.34 | 139.17 | 33.17 | 172.34 | |
65+ | 143.07 | 69.35 | 212.42 | 143.07 | 69.35 | 212.42 | 143.07 | 69.35 | 212.42 | |
Neuropsychiatric conditions | 15 to 34 | 7.06 | 3.03 | 10.09 | 7.06 | 3.03 | 10.09 | 7.06 | 3.03 | 10.09 |
35 to 64 | 135.49 | 45.33 | 180.83 | 135.49 | 45.33 | 180.83 | 135.49 | 45.33 | 180.83 | |
65+ | 130.48 | 36.77 | 167.24 | 130.48 | 36.77 | 167.24 | 130.48 | 36.77 | 167.24 | |
Total | 3345.73 | 932.15 | 4277.88 | 4287.15 | 932.15 | 5219.30 | 4788.67 | 2607.19 | 7395.86 |
Source: www.alcoholharmtool.info
n.p. — not publishable due to cells based on original death counts (i.e. before attributable fractions applied) being ≤5.
xProtective effect methods detailed in InterMAHP guide (see [1] on 'About' page).
*Scenario 1 — Ischaemic heart disease (IHD) relative risk source
Roerecke, M., & Rehm, J. (2012). The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta‐analysis. Addiction, 107(7), 1246-1260.
Roerecke, M., & Rehm, J. (2010). Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. American journal of epidemiology, 171(6), 633-644.
Roerecke, M., & Rehm, J. (2011). Ischemic heart disease mortality and morbidity rates in former drinkers: a meta-analysis. American journal of epidemiology, 173(3), 245-258.
+Scenario 2 — Ischaemic heart disease (IHD) relative risk source
Zhao, J., Stockwell, T., Roemer, A., Naimi, T., Chikritzhs, T. (2017). Alcohol consumption and mortality from coronary heart disease: An updated meta-analysis of cohort studies. Journal of Studies on Alcohol and Drugs, 78, 375-386.
Roerecke, M., & Rehm, J. (2011). Ischemic heart disease mortality and morbidity rates in former drinkers: a meta-analysis. American journal of epidemiology, 173(3), 245-258.
±Scenario 3 — No protective effect
No protective effect achieved by changing relative risks for various Cardiovascular diseases (IHD relative risks from scenario 1 used), Acute pancreatitis (Digestive disease) and Diabetes Mellitus Type 2 (Endocrine condition) from <1 to =1.